|
|
|
|
| LUN501a | 肺腺癌及肺组织组合芯片，附病理分级、TNM和临床分期，50例/50点 | | 点 数 | 50 | 例 数 | 50 | | 行 数 | 6 | 列 数 | 9 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirm | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
* (*) Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) Normal (*) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size | isBackUp |
| A1 | 1 | 52 | M | Lung | Adenocarcinoma | 1--2 | T2N0M0 | IB | Malignant | * | N |
| A2 | 2 | 68 | F | Lung | Adenocarcinoma with necrosis | 2 | T3N1M0 | IIIA | Malignant | * | N |
| A3 | 3 | 49 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | * | N |
| A4 | 4 | 58 | M | Lung | Adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant | 5.0*4.0*4 | N |
| A5 | 5 | 51 | M | Lung | Adenocarcinoma with necrosis | 2 | T3N1M0 | IIIA | Malignant | * | N |
| A6 | 6 | 59 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | * | N |
| A7 | 7 | 42 | M | Lung | Adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | * | N |
| A8 | 8 | 42 | F | Lung | Adenocarcinoma | 2--3 | T3N1M0 | IIIA | Malignant | * | N |
| A9 | 9 | * | * | * | * | * | * | * | * | * | N |
| B1 | 10 | 39 | F | Lung | Adenocarcinoma | 2--3 | T3N0M0 | IIB | Malignant | * | N |
| B2 | 11 | 48 | F | Lung | Adenocarcinoma | 2--3 | T2N0M0 | IB | Malignant | 4*3*2.5 | N |
| B3 | 12 | 68 | F | Lung | Adenocarcinoma | 2--3 | T2N2M0 | IIIA | Malignant | * | N |
| B4 | 13 | 52 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | * | N |
| B5 | 14 | 62 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | * | N |
| B6 | 15 | 64 | M | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | * | N |
| B7 | 16 | 48 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | * | N |
| B8 | 17 | 65 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | 5*4*4 | N |
| B9 | 18 | * | * | * | * | * | * | * | * | * | N |
| C1 | 19 | 40 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 6*5 | N |
| C2 | 20 | 65 | M | Lung | Adenocarcinoma with necrosis | 3 | T3N0M0 | IIB | Malignant | 9*6.5*5 | N |
| C3 | 21 | 64 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 6*5*5 | N |
| C4 | 22 | 35 | F | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | * | N |
| C5 | 23 | 40 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 4*5 | N |
| C6 | 24 | 54 | F | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | * | N |
| C7 | 25 | 50 | M | Lung | Adenocarcinoma | 3 | T2bN1M0 | IIB | Malignant | * | N |
| C8 | 26 | 55 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | 5*4 | N |
| C9 | 27 | * | * | * | * | * | * | * | * | * | N |
| D1 | 28 | 58 | M | Lung | Adenocarcinoma with necrosis (sparse) | 3 | T2N1M0 | IIB | Malignant | * | N |
| D2 | 29 | 50 | F | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant | * | N |
| D3 | 30 | 69 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant | * | N |
| D4 | 31 | 54 | F | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 4*4 | N |
| D5 | 32 | 50 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | * | N |
| D6 | 33 | 65 | F | Lung | Adenocarcinoma with necrosis | 3 | T3N1M0 | IIIA | Malignant | * | N |
| D7 | 34 | 66 | M | Lung | Adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | 6.5*5.0*3.5 | N |
| D8 | 35 | 45 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | * | N |
| D9 | 36 | * | * | * | * | * | * | * | * | * | N |
| E1 | 37 | 59 | M | Lung | Adenocarcinoma | 3 | T2bN1M0 | IIB | Malignant | 5*2.5*2 | N |
| E2 | 38 | 56 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant | 7*7*3.5 | N |
| E3 | 39 | 56 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IIA | Malignant | * | N |
| E4 | 40 | 58 | F | Lung | Adenocarcinoma with necrosis | 3 | T2bN1M0 | IIB | Malignant | 6.5*5.0*4.5 | N |
| E5 | 41 | 70 | M | Lung | Adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant | 5.5*4*3.5 | N |
| E6 | 42 | 53 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 9.5*7*6 | N |
| E7 | 43 | 60 | F | Lung | Adenocarcinoma with necrosis | 3 | T3N0M0 | IIB | Malignant | * | N |
| E8 | 44 | 48 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 6*7 | N |
| E9 | 45 | 45 | F | Lung | Adenocarcinoma | 3 | T2aN0M0 | IIA | Malignant | * | N |
| F1 | 46 | 24 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
| F2 | 47 | 22 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
| F3 | 48 | 55 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
| F4 | 49 | 19 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
| F5 | 50 | 25 | F | Lung | Lung tissue | * | * | * | Normal | * | N |
| F6 | 51 | 40 | F | Lung | Lung tissue | * | * | * | Normal | * | N |
| F7 | 52 | 48 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
| F8 | 53 | 6 Mon | F | Lung | Lung tissue | * | * | * | Normal | * | N |
| F9 | 54 | 43 | M | Lung | Lung tissue | * | * | * | Normal | * | N |
|
|
